Skip to site menu Skip to page content

Daily Newsletter

09 August 2023

Daily Newsletter

09 August 2023

Tufts Medicine and Synchronous Health partner on behavioural health

The partnership will address the increasing demand for behavioural health care in Eastern Massachusetts.

August 09 2023

US-based integrated health system Tufts Medicine has collaborated with Synchronous Health, an evidence-based behavioural healthcare services provider, to enhance access to behavioural healthcare throughout Eastern Massachusetts.

By providing quick and accessible care, the collaboration seeks to give patients' mental health priority along with their physical health.

This alliance will leverage a digital platform that incorporates the Karla AI-powered bot to provide interventions from the care plan at times and locations where patients require support.

According to a statement, the partnership will address the increasing demand for behavioural health care, which has been amplified by factors such as the Covid-19 pandemic.

Synchronous Health connects patients with therapists through scheduled telehealth appointments.

Its AI bot, Karla, provides personalised guidance, coping strategies, and resources tailored to each patient's needs between therapy sessions.

Tufts Medicine Integrated Network, comprising more than 2,300 physicians, will have access to this collaborative telehealth offering.

Tufts Medicine paediatrician Dr Megan Cardoso said: "This partnership with Synchronous Health improves access to certified, qualified therapists to my patients, which previously would have been a one-to-three month wait for kids in crisis.

"In addition, having the Synchronous therapists embedded into our systems means that we can have real-time conversations about patients we are worried about, or who are doing well.

"When we started, many were worried about the telehealth platform, but the truth is that most of my paediatric patients and their families have embraced telehealth and the ability to interact with a therapist in their own comfortable home setting.

"They trust that their doctors are working with these therapists to take the best possible care of them."

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close